Responding to the rising number of suicides using barbiturates

Bridin P Murnion and Darren M Roberts
Med J Aust 2022; 216 (4): . || doi: 10.5694/mja2.51409
Published online: 7 March 2022

Suicide prevention requires ensuring that social media are responsible and accountable, and that poisoning surveillance systems are adequately supported

Barbiturates have a narrow therapeutic index, and accidental or deliberate poisoning can cause coma and cardiorespiratory arrest. Barbiturate‐related death rates were high in the mid‐20th century, when barbiturates were still commonly prescribed, but safer alternatives mean that clinical indications for prescribing them are now extremely limited.1 Over the past twenty years, however, interest in barbiturates has increased, particularly in their use at the end of life.2

  • 1 Western Sydney Local Health District, Sydney, NSW
  • 2 The University of Sydney, Sydney, NSW
  • 3 Children's Hospital at Westmead, Sydney Children's Hospitals Network, Sydney, NSW
  • 4 Royal Prince Alfred Hospital, Sydney, NSW

Competing interests:

No relevant disclosures.

  • 1. Darke S, Chrzanowska A, Campbell G, et al. Barbiturate‐related hospitalisations, drug treatment episodes, and deaths in Australia, 2000–2018. Med J Aust 2022; 216: 194–198.
  • 2. Sinmyee S, Pandit VJ, Pascual JM, et al. Legal and ethical implications of defining an optimum means of achieving unconsciousness in assisted dying. Anaesthesia 2019; 74: 630–637.
  • 3. Campbell G, Darke S, Zahra E, et al. Trends and characteristics in barbiturate deaths Australia 2000–2019: a national retrospective study. Clin Toxicol (Phila) 2021; 59: 224–230.
  • 4. Queensland University of Technology. Voluntary assisted dying. Updated 23 Nov 2021. https://end‐of‐ (viewed Nov 2021).
  • 5. van den Hondel KE, Punt P, Dorn T, et al. The rise of suicides using a deadly dose of barbiturates in Amsterdam and Rotterdam, the Netherlands, between 2006 and 2017. J Forensic Leg Med 2020; 70: 101916.
  • 6. Ryan CJ, Callaghan S. Legal and ethical aspects of refusing medical treatment after a suicide attempt: the Wooltorton case in the Australian context. Med J Aust 2010; 193: 239–242.‐and‐ethical‐aspects‐refusing‐medical‐treatment‐after‐suicide‐attempt
  • 7. Royal Australasian College of Physicians. Voluntary assisted dying. 2020.‐and‐advocacy‐priorities/voluntary‐assisted‐dying (viewed Nov 2021).
  • 8. Jeste DV, Saks E. Decisional capacity in mental illness and substance use disorders: empirical database and policy implications. Behav Sci Law 2006; 24: 607–628.
  • 9. Evenblij K, Pasman HRW, Pronk R, Onwuteaka‐Philipsen BO. Euthanasia and physician‐assisted suicide in patients suffering from psychiatric disorders: a cross‐sectional study exploring the experiences of Dutch psychiatrists. BMC Psychiatry 2019; 19: 74.
  • 10. World Health Organization; International Association for Suicide Prevention. Preventing suicide: a resource for media professionals. Geneva: WHO, 2008. (viewed Nov 2021).
  • 11. Brown J, Berling I, Jiranantakan T, et al. Toxicovigilance for suicide prevention following Internet promotion of sodium nitrite [abstract]. Injury Prev 2021; 27 (Suppl 2): A18‐A.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.